查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1954196

幽門螺旋桿菌檢測市場分析及預測（至2035年）：依類型、產品類型、服務、技術、應用、最終使用者、設備、流程、解決方案分類

Helicobacter Pylori Testing Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Device, Process, Solutions
出版日期: | 出版商: Global Insight Services | 英文 359 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

幽門螺旋桿菌檢測市場預計將從2024年的4.012億美元成長到2034年的8.192億美元，複合年成長率約為8.1%。該市場涵蓋用於檢測幽門螺旋桿菌感染的診斷工具和方法，幽門螺旋桿菌感染與多種胃腸道疾病有關。市場包括尿素呼吸檢測和糞便抗原檢測等非侵入性檢測，以及內視鏡檢查等侵入性檢查。人們對胃腸道健康的日益關注和診斷準確性的提高正在推動市場成長，而對早期檢測和治療幽門螺旋桿菌感染的需求不斷成長，則推動了調查方法的創新。

幽門螺旋桿菌檢測市場持續穩定成長，這主要得益於診斷技術的進步和人們對胃腸道健康意識提升。非侵入性檢測，尤其是尿素呼吸檢測，因其準確度和患者舒適度而日益普及。糞便抗原檢測緊隨其後，提供可靠的結果並具有成本效益。內視鏡切片檢查等侵入性檢測方法對於全面診斷至關重要，尤其是在複雜病例中。儘管血清學檢測市場佔有率有所下降，但它在初步篩檢中仍然發揮作用。臨床上對快速且有效率檢測結果的需求促使市場轉向快速診斷檢測。就地檢驗設備等技術創新正日益普及，提高了檢測的可近性和便利性。研發投入的不斷增加推動了新型檢測方案的採用，進一步促進了市場成長。醫療機構與診斷公司之間的合作對於擴大檢測的可近性和改善患者預後至關重要。

市場區隔
按類型 侵入性和非侵入性檢查
產品 尿素呼吸檢測盒、糞便抗原檢測套組、血清檢測套組、快速檢測套組、PCR試劑盒、內視鏡設備
服務 診斷檢查室、醫院和診所、研究實驗室和學術機構、就地檢驗
科技 免疫檢測、分子診斷、層析法、微生物培養
應用領域 胃腸病學、腫瘤學、感染疾病
最終用戶 醫院、診斷檢查室、研究實驗室和門診護理中心
裝置 內視鏡、分析設備
過程 檢體採集、樣本製備及檢體分析
解決方案 診斷解決方案、篩檢解決方案和監測解決方案

幽門螺旋桿菌檢測市場的調查方法多種多樣，每種方法都對整體市佔率有所貢獻。競爭激烈的定價策略是市場環境的顯著特徵，且因地區和檢測類型而異。頻繁的新產品發布反映了持續的創新和技術進步。這些新產品的發布對於滿足日益成長的對精準、非侵入性檢測解決方案的需求至關重要。新型診斷工具的推出進一步增強了市場的活力，這些工具有望改善患者預後並提高檢測效率。幽門螺旋桿菌檢測市場的競爭異常激烈，許多公司競相爭奪主導。主要競爭對手透過策略聯盟和雄厚的研發投入來脫穎而出。監管影響顯著，嚴格的標準規定了產品核可和市場准入。這些法規在確保高品質檢測解決方案的同時，也對新進入者構成了障礙。在人們對胃腸道健康和早期診斷重要性的認知不斷提高的推動下，市場呈現出成長跡象。不斷擴大的醫療基礎設施和日益成長的全球醫療支出也支撐了這一趨勢。

主要趨勢和促進因素：

幽門螺旋桿菌檢測市場正經歷強勁成長，這主要得益於全球對胃腸道健康問題的意識提升。主要趨勢包括幽門螺旋桿菌感染率的上升，從而推動了對高效、精準診斷檢測的需求。非侵入性檢測方法（例如尿素呼吸檢測和糞便抗原檢測）的技術進步正日益普及，提高了患者的舒適度和診斷準確性。此外，個人化醫療的興起也推動了客製化檢測方案的應用，從而能夠制定更精準的治療方案。將人工智慧和機器學習等先進技術整合到診斷工具中，提高了檢測的靈敏度和特異性。監管機構的支持以及政府主導的旨在早期發現和預防疾病的舉措，進一步推動了市場成長。新興市場蘊藏著許多機遇，這些市場的醫療基礎設施正在快速發展，人們對幽門螺旋桿菌相關疾病的認知也不斷提高。能夠提供經濟高效且便捷的檢測方案的公司將有機會佔據可觀的市場佔有率。人們對預防醫學的興趣日益濃厚，家用檢測套組也越來越受歡迎，這也促進了市場的擴張，為業內相關人員帶來了充滿希望的前景。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 侵入性檢查
    • 非侵入性偵測
  • 市場規模及預測：依產品分類
    • 尿素呼吸檢測試劑盒
    • 糞便抗原檢測套組
    • 血清學檢測套組
    • 快速檢測套組
    • PCR試劑盒
    • 內視鏡設備
  • 市場規模及預測：依服務分類
    • 診斷檢查室
    • 醫院和診所
    • 研究和學術機構
    • 即時檢測
  • 市場規模及預測：依技術分類
    • 免疫檢測
    • 分子診斷
    • 層析法
    • 微生物培養
  • 市場規模及預測：依應用領域分類
    • 胃腸病學
    • 腫瘤學
    • 感染疾病
  • 市場規模及預測：依最終用戶分類
    • 醫院
    • 診斷檢查室
    • 研究所
    • 門診治療中心
  • 市場規模及預測：依設備分類
    • 內視鏡檢查
    • 分析器
  • 市場規模及預測：依製程分類
    • 檢體採集
    • 樣品製備
    • 樣品分析
  • 市場規模及預測：按解決方案分類
    • 診斷解決方案
    • 篩檢解決方案
    • 監控解決方案

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • Meridian Bioscience
  • Quidel Ortho
  • Dia Sorin
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • Sekisui Diagnostics
  • Bio-Rad Laboratories
  • Halyard Health
  • Alere
  • Coris Bio Concept
  • EKF Diagnostics
  • Quest Diagnostics
  • Boditech Med
  • Sercon Group
  • Mobidiag
  • Genedia
  • Trinity Biotech
  • Corgenix Medical
  • Immunodiagnostic Systems

第9章：關於我們

簡介目錄
Product Code: GIS24337

Helicobacter Pylori Testing Market is anticipated to expand from $401.2 million in 2024 to $819.2 million by 2034, growing at a CAGR of approximately 8.1%. The Helicobacter Pylori Testing Market encompasses diagnostic tools and methods used to detect Helicobacter pylori infections, which are linked to gastrointestinal diseases. This market includes non-invasive tests such as urea breath tests and stool antigen tests, alongside invasive procedures like endoscopy. Rising awareness of gastric health and advancements in diagnostic accuracy are propelling market growth, with increasing demand for early detection and treatment of H. pylori infections driving innovation in testing methodologies.

The Helicobacter Pylori Testing Market is experiencing robust expansion, propelled by advancements in diagnostic technologies and rising awareness of gastrointestinal health. Non-invasive tests, particularly the urea breath test, lead in performance due to their accuracy and patient comfort. The stool antigen test follows closely, offering a cost-effective alternative with reliable results. Invasive testing methods, such as endoscopic biopsy, remain essential for comprehensive diagnosis, especially in complex cases. The serology test segment, although declining, still plays a role in initial screenings. The market is also witnessing a shift towards rapid diagnostic tests, driven by the need for quick and efficient results in clinical settings. Technological innovations, such as point-of-care testing devices, are gaining traction, enhancing accessibility and convenience. Increased investment in research and development is fostering the introduction of novel testing solutions, further propelling market growth. Collaboration between healthcare providers and diagnostic companies is crucial in expanding testing accessibility and improving patient outcomes.

Market Segmentation
TypeInvasive Testing, Non-invasive Testing
ProductUrea Breath Test Kits, Stool Antigen Test Kits, Serology Test Kits, Rapid Test Kits, PCR Kits, Endoscopy Devices
ServicesDiagnostic Laboratories, Hospitals and Clinics, Research and Academic Institutes, Point-of-Care Testing
TechnologyImmunoassays, Molecular Diagnostics, Chromatography, Microbiological Culture
ApplicationGastroenterology, Oncology, Infectious Diseases
End UserHospitals, Diagnostic Laboratories, Research Institutes, Ambulatory Care Centers
DeviceEndoscopes, Analyzers
ProcessSample Collection, Sample Preparation, Sample Analysis
SolutionsDiagnostic Solutions, Screening Solutions, Monitoring Solutions

The Helicobacter Pylori Testing Market is characterized by a diverse array of testing methodologies, each contributing to the overall market share. The landscape is marked by competitive pricing strategies, which vary significantly across regions and testing types. New product launches are frequent, reflecting ongoing innovation and technological advancements. These launches are pivotal in addressing the growing demand for accurate and non-invasive testing solutions. The market's dynamism is further enhanced by the introduction of novel diagnostic tools, which promise to improve patient outcomes and streamline testing processes. Competition within the Helicobacter Pylori Testing Market is intense, with numerous players vying for dominance. Key competitors are distinguished by their strategic alliances and robust R&D investments. Regulatory influences play a significant role, with stringent standards governing product approvals and market entry. These regulations ensure high-quality testing solutions but also pose barriers to new entrants. The market is poised for growth, driven by increasing awareness of gastrointestinal health and the importance of early diagnosis. This trend is supported by the expansion of healthcare infrastructure and rising healthcare expenditure globally.

Geographical Overview:

The Helicobacter Pylori Testing Market is witnessing diverse growth patterns across various regions, each presenting unique opportunities. North America maintains a dominant position owing to advanced healthcare infrastructure and heightened awareness about gastrointestinal health. The region's emphasis on preventive healthcare further propels market growth. Europe follows suit, with robust healthcare systems and increasing prevalence of Helicobacter Pylori infections driving demand for testing solutions. Asia Pacific is emerging as a significant growth pocket, primarily due to rising healthcare expenditure and improving diagnostic facilities. Countries like China and India are at the forefront, with their expanding healthcare sectors and increasing public awareness contributing to market expansion. Additionally, the growing prevalence of gastrointestinal disorders in these regions underscores the need for effective testing methods. In Latin America, Brazil and Mexico are notable for their increasing adoption of advanced diagnostic technologies. Meanwhile, the Middle East & Africa are gradually recognizing the importance of early detection, with countries like the UAE showing promising growth potential.

The global Helicobacter Pylori Testing Market is influenced by tariffs, geopolitical risks, and supply chain dynamics, particularly in East Asia. Japan and South Korea, with their advanced healthcare systems, are adapting to trade tensions by enhancing domestic production capabilities and exploring regional partnerships. China's strategy involves boosting local innovation to mitigate reliance on imports amid US-China trade frictions. Taiwan, a pivotal player in biotech, navigates geopolitical challenges while maintaining its supply chain resilience. The parent market is witnessing robust growth globally, driven by rising gastrointestinal disease awareness and technological advancements. By 2035, the market is poised for substantial expansion, contingent on geopolitical stability and supply chain agility. Middle East conflicts continue to exert pressure on global energy prices, indirectly affecting production costs and logistics.

Key Trends and Drivers:

The Helicobacter Pylori Testing Market is experiencing robust growth fueled by rising awareness of gastrointestinal health issues globally. Key trends include the increasing prevalence of Helicobacter pylori infections, which has heightened the demand for efficient and accurate diagnostic tests. Technological advancements in non-invasive testing methods, such as urea breath tests and stool antigen tests, are gaining traction, offering improved patient comfort and diagnostic accuracy. Moreover, the shift towards personalized medicine is driving the adoption of tailored testing solutions, enabling more precise treatment regimens. The integration of advanced technologies like artificial intelligence and machine learning in diagnostic tools is enhancing test sensitivity and specificity. Regulatory support and government initiatives aimed at early disease detection and prevention are further propelling market growth. Opportunities abound in emerging markets where healthcare infrastructure is rapidly developing, and awareness of Helicobacter pylori-related conditions is increasing. Companies that can offer cost-effective and accessible testing solutions stand to gain significant market share. The growing emphasis on preventive healthcare and the increasing availability of home testing kits are also contributing to the market's expansion, presenting lucrative prospects for industry players.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Device
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Invasive Testing
    • 4.1.2 Non-invasive Testing
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Urea Breath Test Kits
    • 4.2.2 Stool Antigen Test Kits
    • 4.2.3 Serology Test Kits
    • 4.2.4 Rapid Test Kits
    • 4.2.5 PCR Kits
    • 4.2.6 Endoscopy Devices
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Diagnostic Laboratories
    • 4.3.2 Hospitals and Clinics
    • 4.3.3 Research and Academic Institutes
    • 4.3.4 Point-of-Care Testing
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Immunoassays
    • 4.4.2 Molecular Diagnostics
    • 4.4.3 Chromatography
    • 4.4.4 Microbiological Culture
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Gastroenterology
    • 4.5.2 Oncology
    • 4.5.3 Infectious Diseases
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals
    • 4.6.2 Diagnostic Laboratories
    • 4.6.3 Research Institutes
    • 4.6.4 Ambulatory Care Centers
  • 4.7 Market Size & Forecast by Device (2020-2035)
    • 4.7.1 Endoscopes
    • 4.7.2 Analyzers
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Sample Collection
    • 4.8.2 Sample Preparation
    • 4.8.3 Sample Analysis
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Diagnostic Solutions
    • 4.9.2 Screening Solutions
    • 4.9.3 Monitoring Solutions

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Device
      • 5.2.1.8 Process
      • 5.2.1.9 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Device
      • 5.2.2.8 Process
      • 5.2.2.9 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Device
      • 5.2.3.8 Process
      • 5.2.3.9 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Device
      • 5.3.1.8 Process
      • 5.3.1.9 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Device
      • 5.3.2.8 Process
      • 5.3.2.9 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Device
      • 5.3.3.8 Process
      • 5.3.3.9 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Device
      • 5.4.1.8 Process
      • 5.4.1.9 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Device
      • 5.4.2.8 Process
      • 5.4.2.9 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Device
      • 5.4.3.8 Process
      • 5.4.3.9 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Device
      • 5.4.4.8 Process
      • 5.4.4.9 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Device
      • 5.4.5.8 Process
      • 5.4.5.9 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Device
      • 5.4.6.8 Process
      • 5.4.6.9 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Device
      • 5.4.7.8 Process
      • 5.4.7.9 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Device
      • 5.5.1.8 Process
      • 5.5.1.9 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Device
      • 5.5.2.8 Process
      • 5.5.2.9 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Device
      • 5.5.3.8 Process
      • 5.5.3.9 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Device
      • 5.5.4.8 Process
      • 5.5.4.9 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Device
      • 5.5.5.8 Process
      • 5.5.5.9 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Device
      • 5.5.6.8 Process
      • 5.5.6.9 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Device
      • 5.6.1.8 Process
      • 5.6.1.9 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Device
      • 5.6.2.8 Process
      • 5.6.2.9 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Device
      • 5.6.3.8 Process
      • 5.6.3.9 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Device
      • 5.6.4.8 Process
      • 5.6.4.9 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Device
      • 5.6.5.8 Process
      • 5.6.5.9 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Meridian Bioscience
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Quidel Ortho
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Dia Sorin
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 F. Hoffmann- La Roche
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Thermo Fisher Scientific
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Abbott Laboratories
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Sekisui Diagnostics
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Bio- Rad Laboratories
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Halyard Health
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Alere
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Coris Bio Concept
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 EKF Diagnostics
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Quest Diagnostics
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Boditech Med
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Sercon Group
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Mobidiag
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Genedia
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Trinity Biotech
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Corgenix Medical
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Immunodiagnostic Systems
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us